Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-30

FDA Approved: VESTURA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's supplemental application for VESTURA, a generic combination oral contraceptive containing drospirenone and ethinyl estradiol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VESTURA (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for VESTURA (DROSPIRENONE AND ETHINYL ESTRADIOL)